+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
BMLL

Bio Medica Laboratories Share Price

 

 

Bio Medica Laboratories live price: ₹144.1. It opened at ₹148 vs previous close ₹143; intraday high/low: ₹148/₹140.

Bio Medica Laboratories Performance

  • Today's Low
  • ₹140
  • Today's High
  • ₹148
  • 52 Week Low
  • ₹102
  • 52 Week High
  • ₹148
  • Open Price₹148
  • Previous Close₹143
  • Volume101,000
  • 50 DMA-
  • 100 DMA-
  • 200 DMA-

Bio Medica Laboratories Chart

Investment Returns

  • Over 1 Month + 3.67%
  • Over 3 Month + 3.67%
  • Over 6 Month + 3.67%
  • Over 1 Year + 3.67%

Smart Investing Starts Here Start SIP with Bio Medica Laboratories for Steady Growth!

Invest Now

Bio Medica Laboratories Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 68.9
  • PEG Ratio
  • -
  • Market Cap Cr
  • 181
  • P/B Ratio
  • 10.2
  • Average True Range
  • 7.42
  • EPS
  • 0
  • Dividend Yield
  • 0
  • MACD Signal
  • -
  • RSI
  • 67.42
  • MFI
  • 49.68

Bio Medica Laboratories Financials

Bio Medica Laboratories Technicals

EMA & SMA

Current Price
₹144.10
+ 0.7 (0.49%)
pointer
  • Bearish Moving Average 0
  • Bullish Moving Average 7
  • 20 Day
  • ₹128.10
  • 50 Day
  • -
  • 100 Day
  • -
  • 200 Day
  • -

Resistance and Support

144.03 Pivot Speed
  • R3 156.07
  • R2 152.03
  • R1 148.07
  • S1 140.07
  • S2 136.03
  • S3 132.07

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

N/A

Group Rank

Bio Medica Laboratories Ltd manufactures parenteral formulations and injectable products for human and veterinary healthcare. Its portfolio includes domestic and export-oriented injectables. The company serves healthcare and animal health markets, providing products used for treatment, disease management, and patient care.

Bio Medica Laboratories Ltd has an operating revenue of Rs. 65.63 Cr. on a trailing 12-month basis. ROE of 49% is exceptional. The stock from a technical standpoint is comfortably placed above its key moving averages, around 11% and 11% from 50DMA and 200DMA. From an O'Neil Methodology perspective, the stock has an EPS Rank of 75 which is a FAIR score but needs to improve its earnings, a RS Rating of 88 which is GOOD indicating the outperformance as compared to other stocks, Group Rank of 44 indicates it belongs to a fair industry group of Medical-Generic Drugs and a Master Score of C is fair but needs to improve. Overall, the stock is lagging behind in earnings parameter, but excellent technical strength makes it a stock to examine in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Bio Medica Laboratories Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-06-22 Others To consider Other business matters.

Bio Medica Laboratories Shareholding Pattern

67.7%
0.29%
21.38%
10.63%

Bio Medica Laboratories FAQs

Bio Medica Laboratories share price is ₹144 As on 28 June, 2026 | 18:18

The Market Cap of Bio Medica Laboratories is ₹181.2 Cr As on 28 June, 2026 | 18:18

The P/E ratio of Bio Medica Laboratories is 68.9 As on 28 June, 2026 | 18:18

The PB ratio of Bio Medica Laboratories is 10.2 As on 28 June, 2026 | 18:18

Open FREE Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23